$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers to invest $40 billion in the US over 5 years, CEO says
05:23pm, Monday, 05'th May 2025
Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion piece published by Stat News on Monday.
First-Quarter GDP Halfway to Recession: Move to These Safe High-Yield Dividend Stocks Now
07:15am, Thursday, 01'st May 2025
The first report for U.S. gross domestic product (GDP) came in at −0.3% as the economy contracted for the first time in three years.
This High-Yield Pharma Stock Looks Like an Incredible Bargain
06:45am, Wednesday, 30'th Apr 2025
When markets get choppy, smart investors often seek refuge in pharmaceutical stocks. These companies typically offer consistent cash flows, essential products, and solid dividends regardless of econom
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
10:00am, Tuesday, 29'th Apr 2025
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?
10:20am, Monday, 28'th Apr 2025
Bristol Myers' first-quarter performance and raised annual guidance are encouraging. However, we recommend investors to stay on the sidelines as generic competition for legacy drugs and recent pipelin
Top 3 Health Care Stocks That May Rocket Higher In April
07:16am, Monday, 28'th Apr 2025
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap
07:15am, Monday, 28'th Apr 2025
Earnings season offers opportunities to buy undervalued blue-chip stocks like Verizon and Bristol Myers Squibb, both yielding 5-7% and trading below historical PE ratios. Verizon's growth in 5G, broad
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
06:05pm, Saturday, 26'th Apr 2025
It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. Dividend-paying companies tend to have strong un
5 Positives From Bristol-Myers Squibb's Q1 2025 Results
10:27am, Friday, 25'th Apr 2025
Bristol-Myers Squibb's Q1 2025 results confirm that the stock has significant potential upside now. The company's Growth Portfolio showed healthy sales increase, while the non-GAAP EPS surprised posit
Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance
09:00am, Friday, 25'th Apr 2025
Despite recent underperformance, Bristol-Myers' strong cash position, robust pipeline, and strategic acquisitions position it for future growth, making it an undervalued opportunity. BMY's growth port
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
01:11pm, Thursday, 24'th Apr 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Thursday.
BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook
12:55pm, Thursday, 24'th Apr 2025
BMY beats on both earnings and sales in the first quarter of 2025. The company raises its guidance for the full year.
Jobless Claims Increased in Line With Expectations
12:35pm, Thursday, 24'th Apr 2025
Ahead of the opening bell this Thursday morning, Initial Jobless Claims came in at 222K for last week, slightly above estimates but certainly within range that demonstrates a continued healthy labor m
Bristol-Myers Squibb Company (BMY) Q1 2025 Earnings Call Transcript
12:01pm, Thursday, 24'th Apr 2025
Bristol-Myers Squibb Company (NYSE:BMY ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Chuck Triano - SVP and Head of IR Chris Boerner - Board Chair and CEO David Elk
Bristol-Myers Squibb Is A Good Pick
11:56am, Thursday, 24'th Apr 2025
Bristol-Myers Squibb Company is undervalued, trading 30% below its intrinsic value, with a low price-to-free-cash-flow ratio indicating a strong buying opportunity. In the first quarter, Bristol-Myers
Sign In
Buy BMY